MUC16 and cancer: Traditional serum-based protein biomarkers (cancer antigen-125 (CA-125), cancer antigen 19-9 (CA 19-9), carcinoembryonic antigen (CEA), and prostate-specific antigen (PSA)) are commonly used for monitoring cancer progression but not for cancer diagnosis [41].